Carbamazepine toxicity after starting combination antiretroviral therapy including ritonavir and efavirenz

被引：22
作者：
Burman, W [1 ]
Orr, L
机构：
[1] Denver Hlth, Infect Dis Clin, Denver, CO USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA
来源：
AIDS | 2000年 / 14卷 / 17期
关键词：
D O I：
10.1097/00002030-200012010-00022
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2793 / 2794
页数：2
相关论文
共 9 条
  • [1] Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir
    Eagling, VA
    Back, DJ
    Barry, MG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (02) : 190 - 194
  • [2] FISKE WD, 1997, 4 C RETR OPP INF WAS
  • [3] GALLICANO K, 2000, 7 C RETR OPP INF SAN
  • [4] HUMAN LIVER CARBAMAZEPINE METABOLISM - ROLE OF CYP3A4 AND CYP2C8 IN 10,11-EPOXIDE FORMATION
    KERR, BM
    THUMMEL, KE
    WURDEN, CJ
    KLEIN, SM
    KROETZ, DL
    GONZALEZ, FJ
    LEVY, RH
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (11) : 1969 - 1979
  • [5] CARBAMAZEPINE INTOXICATION DUE TO TRIACETYLOLEANDOMYCIN ADMINISTRATION IN EPILEPTIC PATIENTS
    MESDJIAN, E
    DRAVET, C
    CENRAUD, B
    ROGER, J
    [J]. EPILEPSIA, 1980, 21 (05) : 489 - 496
  • [6] PISCITELLI S, 2000, 7 C RETR OPP INF SAN
  • [7] Drug interactions in patients infected with human immunodeficiency virus
    Piscitelli, SC
    Flexner, C
    Minor, JR
    Polis, MA
    Masur, H
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 685 - 693
  • [8] Clinically significant pharmacokinetic drug interactions with carbamazepine - An update
    Spina, E
    Pisani, F
    Perucca, E
    [J]. CLINICAL PHARMACOKINETICS, 1996, 31 (03) : 198 - 214
  • [9] Ritonavir enables combined therapy with rifampin and saquinavir
    Veldkamp, AI
    Hoetelmans, RMW
    Beijnen, JH
    Mulder, JW
    Meenhorst, PL
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) : 1586 - 1586
1